Non-alcoholic fatty liver disease (NAFLD) is caused by an accumulation of fat in the liver; the
condition can progress over time to increase the risk of developing cirrhosis, end-stage liver …

During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Hepatitis C virus (HCV) infected patients are known to be at risk of developing liver
complications ie cirrhosis and liver cancer. However, the risks of morbidity and mortality are …

Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

Hepatitis C virus (HCV) infection is considered a systemic disease because of involvement
of other organs and tissues concomitantly with liver disease. Among the extrahepatic …

Chronic hepatitis C (CHC) is associated with multiple extrahepatic manifestations that may
impact infected patients. The mechanisms through which these develop include those which …

Abstract Coronavirus disease 2019 (Covid-19) is a novel worldwide pandemic caused by a
novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). During Covid-19 …

Background and aims Extrahepatic manifestations of HCV are responsible for morbidity and
mortality in many chronically infected patients. New, interferon-free antiviral treatment …

Hepatitis C virus (HCV) infection is responsible for both hepatic and extra-hepatic disorders
(HCV-EHDs); these latter are correlated on one hand clearly with HCV lymphotropism …

Background: The findings on the association between elevated plasma homocysteine levels
and the risk of the trial of org 10172 in acute stroke treatment (TOAST) of ischemic stroke …